The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification and characterization of four bacteriome- and mycobiome-derived subtypes in tumour and adjacent mucosa tissue of colorectal cancer patients.
 
Manuela Salvucci
Employment - Benevolent AI
 
Liam Poynter
No Relationships to Disclose
 
Reza Mirnezami
No Relationships to Disclose
 
Steven Carberry
No Relationships to Disclose
 
Robert O'Byrne
No Relationships to Disclose
 
James Alexander
No Relationships to Disclose
 
Diether Lambrechts
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Eisai; F. Hoffmann LaRoche; Genmab; GlaxoSmithKline; ImmunoGen; Merck Serono; MSD; Novartis; PharmaMar
Research Funding - Clovis Oncology; GlaxoSmithKline; MSD
 
Kirill Veselkov
No Relationships to Disclose
 
James M. Kinross
Leadership - GetWell Media; OneWelbeck
Stock and Other Ownership Interests - SurgEase
Honoraria - Yakult Pharmaceutical
Consulting or Advisory Role - Concentrx; Johnson & Johnson; SafeHeal
Research Funding - Intuitive Surgical; Johnson & Johnson
Patents, Royalties, Other Intellectual Property - IEndoscope
Travel, Accommodations, Expenses - Intuitive Surgical
 
Jochen Prehn
Patents, Royalties, Other Intellectual Property - Inventor on Patent Application oWO2013001002 - A COMPUTER-IMPLEMENTED SYSTEM AND METHOD FOR THE PREDICTION OF CANCER RESPONSE TO GENOTOXIC CHEMOTHERAPY AND PERSONALISED NEOADJUVANT TREATMENTS (PCCP) describing the use of Apoptocell modeling as prognostic
Expert Testimony - Boehringer Ingelheim